Moseman; Elliott Ashley

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moseman; Elliott Ashley.The latest application filed is for "vaccine nanotechnology".

Company Profile

3.23.13

Moseman; Elliott Ashley - Jamaica Plain NY US
Moseman; Elliott Ashley - Rockville MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Vaccine nanotechnology Grant 10,736,848 - Von Andrian , et al. A	2020-08-11
Vaccine Nanotechnology App 20200054559 - von Andrian; Ulrich H. ; et al.	2020-02-20
Vaccines comprising bisphosphonate and methods of use thereof Grant 10,188,733 - von Andrian , et al. Ja	2019-01-29
Vaccine nanotechnology Grant 9,539,210 - von Andrian , et al. January 10, 2	2017-01-10
Vaccine nanotechnology Grant 9,526,702 - von Andrian , et al. December 27, 2	2016-12-27
Vaccine nanotechnology Grant 9,474,717 - von Andrian , et al. October 25, 2	2016-10-25
Adjuvant incorporation in immunoanotherapeutics Grant 9,439,859 - Alexis , et al. September 13, 2	2016-09-13
Targeting of antigen presenting cells with immunonanotherapeutics Grant 9,308,280 - Shi , et al. April 12, 2	2016-04-12
Adjuvant incorporation in immunonanotherapeutics Grant 9,233,072 - Alexis , et al. January 12, 2	2016-01-12
Nicotine immunonanotherapeutics Grant 8,932,595 - Iannacone , et al. January 13, 2	2015-01-13
Immunonanotherapeutics that provide IGG humoral response without T-cell antigen Grant 8,906,381 - Iannacone , et al. December 9, 2	2014-12-09
Vaccine Nanotechnology App 20140314865 - von Andrian; Ulrich H. ; et al.	2014-10-23
Adjuvant Incorporation in Immunonanotherapeutics App 20140127301 - Alexis; Frank ; et al.	2014-05-08
Targeting of Antigen Presenting Cells With Immunonanotherapeutics App 20140037736 - Shi; Jinjun ; et al.	2014-02-06
Adjuvant incorporation in immunonanotherapeutics Grant 8,637,028 - Alexis , et al. January 28, 2	2014-01-28
Nicotine immunonanotherapeutics Grant 8,591,905 - von Andrian , et al. November 26, 2	2013-11-26
Vaccines Comprising Bisphosphonate And Methods Of Use Thereof App 20130309270 - von Andrian; Ulrich H. ; et al.	2013-11-21
Vaccine Nanotechnology App 20130287857 - von Andrian; Ulrich H. ; et al.	2013-10-31
Targeting of antigen presenting cells with immunonanotherapeutics Grant 8,562,998 - Shi , et al. October 22, 2	2013-10-22
Vaccine Nanotechnology App 20130236533 - von Andrian; Ulrich H. ; et al.	2013-09-12
Adjuvant Incorporation in Immunonanotherapeutics App 20130129790 - Alexis; Frank ; et al.	2013-05-23
Adjuvant incorporation in immunonanotherapeutics Grant 8,343,498 - Alexis , et al. January 1, 2	2013-01-01
Targeting of antigen presenting cells with immunonanotherapeutics Grant 8,343,497 - Shi , et al. January 1, 2	2013-01-01
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen Grant 8,277,812 - Iannacone , et al. October 2, 2	2012-10-02
IMMUNONANOTHERAPEUTICS THAT PROVIDE IgG HUMORAL RESPONSE WITHOUT T-CELL ANTIGEN App 20120087890 - Iannacone; Matteo ; et al.	2012-04-12
Adjuvant Incorporation In Immunonanotherapeutics App 20110268805 - Alexis; Frank ; et al.	2011-11-03
Targeting Of Antigen Presenting Cells With Immunonanotherapeutics App 20110268804 - Shi; Jinjun ; et al.	2011-11-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.